All patients with the t(11; 16)(q23; p13.3) That involves MLL and CBP have treatment-related hematologic disorders

Janet D. Rowley, Shalini Reshmi, Olatoyosi Sobulo, Tarannum Musvee, John Anastasi, Susana Raimondi, Nancy R. Schneider, Julio C. Barredo, Eduardo S. Cantu, Brigitte Schlegelberger, Frederick Behm, Norman A. Doggett, Julian Borrow, Nancy Zeleznik-Le

Research output: Contribution to journalArticlepeer-review

202 Scopus citations

Fingerprint

Dive into the research topics of 'All patients with the t(11; 16)(q23; p13.3) That involves MLL and CBP have treatment-related hematologic disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds